VIE - Viela Bio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
Total Revenue
20,000
0
Cost of Revenue
-
-
Gross Profit
-
-
Operating Expenses
Research Development
85,635
42,414
Selling General and Administrative
26,741
6,565
Total Operating Expenses
112,376
192,312
Operating Income or Loss
-92,376
-192,312
Interest Expense
-
-
Total Other Income/Expenses Net
-
-143,333
Income Before Tax
-89,913
-190,270
Income Tax Expense
-
-
Income from Continuing Operations
-89,913
-190,270
Net Income
-89,913
-190,270
Net Income available to common shareholders
-89,913
-190,270
Reported EPS
Basic
-
-8.00
Diluted
-
-8.00
Weighted average shares outstanding
Basic
-
24,148
Diluted
-
24,148
EBITDA
-
-192,294